Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease.
about
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeA novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coliPotent immune responses induced by a Salmonella ghost delivery system that expresses the recombinant Stx2eB, FedF, and FedA proteins of the Escherichia coli-producing F18 and Shiga toxin in a murine model and evaluation of its protective effect as a
P2860
Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of recombinant form ...... against porcine edema disease.
@en
Evaluation of recombinant form ...... against porcine edema disease.
@nl
type
label
Evaluation of recombinant form ...... against porcine edema disease.
@en
Evaluation of recombinant form ...... against porcine edema disease.
@nl
prefLabel
Evaluation of recombinant form ...... against porcine edema disease.
@en
Evaluation of recombinant form ...... against porcine edema disease.
@nl
P2093
P2860
P356
P1476
Evaluation of recombinant form ...... against porcine edema disease
@en
P2093
Eiji Takita
Kazutoshi Sawada
Sou-Ichi Makino
Toshio Sato
Yumiko Kadoyama
P2860
P304
P356
10.1292/JVMS.13-0118
P577
2013-07-03T00:00:00Z